Immunotherapy Program
CAR T cells armed with IL-15 show promise in treating solid cancers (Baylor College of Medicine - November 27, 2024)
The future of immunotherapy: Using the body’s immune system to fight cancer (Texas Children's Hospital - November 26, 2024)
Outpatient CAR T: Safe, effective, accessible (MedScape - November 1, 2024)
Baylor College of Medicine receives more than $17 million from CPRIT (Baylor College of Medicine - August 21, 2024)
Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’ (Healio - July 23, 2024)
Novel T-cell therapy effective against common viruses after stem cell transplantation (HemOnc Today - January 12, 2023)
An investigational T-cell therapy shows promise against six viral infections common after stem cell transplants (American Association for Cancer Research - January 11, 2023)
Pilot grants awarded to researchers for innovative therapies (September 7, 2022 - Texas Children's Hospital)
See How LLS® Is Funding Life-Saving Research (Leukemia & Lymphoma Society - September 5, 2022)
New study shows “Living Drug” can provide a lasting cure for cancer (Leaps - March 23, 2022)
Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College of Medicine present new clinical data on GD2 CAR-NKT cells in neuroblastoma at ASGCT Annual Meeting (Athenex - May 17, 2021)
Baylor and TCH researchers honored with AACR Team Science Award (Baylor College of Medicine - April 15, 2021)
Administering CAR T-cell therapy to younger patients requires ‘ongoing and open’ relationships (Healio - March 24, 2021)
Despite challenges, CAR-T may have ‘expanded role’ for children (Healio - February 23, 2021)
Curing Kids Cancer gives $1.5 Million to childhood cancer research projects (Digital Journal - February 4, 2021)
The Faris Foundation grant funds research for advanced sarcoma clinical trial (Baylor College of Medicine - December 4, 2020)
Hegde and team receive funding from The Faris Foundation for advanced sarcoma clinical trial (Texas Children's Hospital - December 2, 2020)
CAR NKT cells, a promising step forward in the treatment of solid tumors ( Baylor College of Medicine - November 10, 2020)
CAR NKT cells offer a promising novel immunotherapy for solid tumors (Baylor College of Medicine - October 12, 2020)
Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells (Baylor College of Medicine - August 20, 2020)
CAR T cell immunotherapy results in patient recovery (Baylor College of Medicine - July 15, 2020)
New approach called nano-radiomics assesses changes in the tumor microenvironment (Baylor College of Medicine - July 13, 2020)
CAR T cell therapy promising treatment for recurrent pediatric brain cancer (Medical Dialogues - May 3, 2020)
Promising new treatment for recurrent pediatric brain cancer (Baylor College of Medicine - April 27, 2020)
Texas Children’s unveils Sky High for Kids Immunotherapy Center on 7 West Tower (Texas Children's Hospital - February 18, 2020)
Sky-high efforts: Nonprofit raises money for pediatric cancer (Midland Reporter-Telegram - November 26, 2019)
Cancer Center on forefront of cutting-edge research, clinical trials (Texas Children's Hospital - September 17, 2019)
Body of Work podcast: Harnessing the body’s immune system to fight cancer (Baylor College of Medicine - September 16, 2019)
Baylor awarded CPRIT grants to support cancer research (Baylor College of Medicine - August 23, 2019)
Professor optimistic cancer will become less life-threatening (Otago Daily Times - August 14, 2019)
Trial underway in US uses CRISPR gene-editing in people with severe sickle cell disease (CNN Health - July 30, 2019)
New genetic weapons challenge sickle cell disease (ScienceDaily - June 3, 2019)
New experimental therapy CAR NKT-cells tested In cancer patients for the first time (Forbes - May 1, 2019)
Joseph, Hegde receive Immunotherapy Scholar Award from the Faris Foundation (Texas Children's Hospital - April 9, 2019)
Cancer treatment uses genetically modified cells to fight tumors (CBS - April 1, 2019)
Heslop receives lifetime achievement award (Texas Children's Hospital - March 11, 2019)
Houston-area physicians, scientists receive a combined $38.1M for cancer research (Houston Business Journal - February 22, 2019)
Marker Therapeutics congratulates Helen E. Heslop, MD, DSc (Hon) on receiving the ASBMT Lifetime Achievement Award (MarketWatch - February 21, 2019)
CPRIT changing lives of childhood cancer survivors (mySA - February 17, 2019)
$5 million grant to expand blood cancer therapy options (Baylor College of Medicine - October 18, 2018)
First neuroblastoma patient successfully dosed with innovative CAR therapy utilizing natural killer T cells (CAR-NKT) (Cell Medica - September 27, 2018)
CPRIT awards $6 million to find new biomarkers and therapies for childhood liver cancers (Texas Children's Hospital - September 19, 2018)
Baylor awarded CPRIT Grants for research, recruitment (Baylor College of Medicine - August 27, 2018)
First-in-human clinical trial aims to treat neuroblastoma (Baylor College of Medicine - June 15, 2018)
How 'Sky High' is raising millions for cancer research (ABC 13 KTRK - May 21, 2018)
Alex’s Lemonade Stand funds Phase 1 neuroblastoma trial (Baylor College of Medicine - December 04, 2017)
Clinical trial shows ready-to-use cells are safe and effective to treat viral infections (Baylor College of Medicine - August 07, 2017)
First-of-its-kind therapy has cancer experts excited (Houston Chronicle - July 13, 2017)
Heslop to lead cell and gene therapy society (Baylor College of Medicine - May 23, 2017)
Clinical trial results show benefit of brain cancer therapy (Baylor College of Medicine - April 24, 2017)
Grant to fund potential new glioblastoma treatment research (Texas Children's Hospital - April 08, 2017)
Texas Children’s Cancer Center to host neuroblastoma research conference (Texas Children's Hospital - April 08, 2017)
International Neuroblastoma Research Conference will be May 3-5, 2017 (Texas Children's Hospital - January 17, 2017)
CPRIT awards additional $7 million to individual investigators (Baylor College of Medicine - November 21, 2016)
Dr. Malcolm Brenner named to National Academy of Medicine (Texas Children's Hospital - October 18, 2016)
Special T cells that target solid tumors offer potential treatment for pediatric and adult cancers (Texas Children's Hospital - September 20, 2016)
Selective predators: Natural killer T cells take aim at solid tumors (Texas Children's Hospital - September 13, 2016)
Children’s cancer research at Baylor, Texas Children’s Cancer Center funded by St. Baldrick’s Foundation (Texas Children's Hospital - August 23, 2016)
Researchers uncover marker important to effectiveness of natural killer T cells (Texas Children's Hospital - May 20, 2016)
Shine a light on neuroblastoma (TMC News - February 03, 2016)
Neuroblastoma research at Baylor receives funding through support of Today show viewers (Texas Children's Hospital - December 18, 2015)
Texas Children's Cancer and Hematology Center
Cell Therapy and Bone Marrow Transplant
